A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10549-007-9494-y.pdf
Reference61 articles.
1. Suzuki T, Moriya T, Ishida T et al (2003a) Intracrine mechanism of estrogen synthesis in breast cancer. Biomed Pharmacother 57(10):460–462
2. Thijssen JH (2004) Local biosynthesis and metabolism of oestrogens in the human breast. Maturitas 49(1):25–33
3. Buzdar AU (2001) Endocrine therapy in the treatment of metastatic breast cancer. Semin Oncol 28(3):291–304
4. Nicholson RI, Johnston SR (2005) Endocrine therapy-current benefits and limitations. Breast Cancer Res Treat 93(Suppl 1):S3–S10
5. Howell SJ, Johnston SR, Howell A (2004) The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer. Best Pract Res Clin Endocrinol Metab 18(1):47–66
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synthesis, biological evaluation, and stability studies of raloxifene mono- and bis-sulfamates as dual-targeting agents;Bioorganic & Medicinal Chemistry;2024-03
2. LINC01116 affects patient survival differently and is dissimilarly expressed in ER+ and ER− breast cancer samples;Cancer Reports;2023-06-15
3. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis;Frontiers in Endocrinology;2022-12-05
4. 16-Picolyl-androsterone derivative exhibits potent 17β-HSD3 inhibitory activity, improved metabolic stability and cytotoxic effect on various cancer cells: Synthesis, homology modeling and docking studies;The Journal of Steroid Biochemistry and Molecular Biology;2021-06
5. Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate Cancer;Clinical Cancer Research;2020-09-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3